following reports that people who had received it developed rare blood clots and that some had died, further slowing Europe’s already slow vaccination rollout.
On Wednesday, EMA officials said that most clots that have been identified were in people under age 60 and women, but cautioned that the data didn’t pinpoint a clear link because it remained unclear how representative recipients of the AstraZeneca vaccine are within the overall population. “Some of that could be explained by how the vaccine is being used,” said Sabine Straus, chair of the EMA’s safety committee, of possible higher-risk groups.
EMA Executive Director Emer Cooke said that because the clots are so rare, the risk of death from Covid-19 is much greater than the risk of dying from the possible side effects.Europe's top drug regulator endorsed AstraZeneca's vaccine after it was suspended in several countries over blood-clot concerns. WSJ explains what's at stake for a shot that's been widely used around the world and may soon be considered for emergency use in the U.S.
Benefits outweigh risks 😂🤣.. it’s sorta rare, so don’t even worry about it. Probably won’t happen. You’ll definitely be protected from the virus and we’ll follow up on those new blood clots 🤷🏻♂️
Officially admitted - British Astra Zeneca side effects is death
That's a strange thing for the EU's health agency to say considering that no vaccine has a better survivable rate against COVID than the 99% natural immunity people have against it.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.